Amy Powers

3.9k citations
40 papers · 2.7k indexed · 1 hit paper · h-index 20

Impact in

    • Occupational and environmental lung diseases
    • Pleural and Pulmonary Diseases
    • Medical Imaging and Pathology Studies
    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
    • Cancer Research and Treatments

Papers in

    • Blood transfusion and management 5
    • Occupational and environmental lung diseases 17
    • Medical Imaging and Pathology Studies 8
    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 4

Amy Powers

40 papers receiving 2.6k citations

Hit Papers

Germline BAP1 mutations predispose to malignant mesothelioma 2011 · 719 citations
7192011202620162021200400600

Peers

Amy Powers
Comparison fields: 5 of 115
  • Pulmonary and Respiratory Medicine 1.4k
  • Biotechnology 215
  • Oncology 671
  • Biochemistry 110
  • Clinical Biochemistry 117
Replace Michael Sheaff with:
Michael Sheaff United Kingdom
Keiichi Iwaya Japan
Kirk J. Wojno United States
Suresh H. Advani India
Fritz Wrba Austria
M. Craig Hall United States
Peter C. Harpel United States
Jen-Kou Lin Taiwan
Yoshiaki Inayama Japan
Mario Taffurelli Italy
Amy Powers relative to Michael Sheaff United Kingdom Michael Sheaff's profile →
Citations per field
00.5×11.7×
Michael Sheaff · 1×
Citations per year

Countries citing papers authored by Amy Powers

Since Specialization
Citations

This map shows the geographic impact of Amy Powers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Powers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Powers more than expected).

Fields of papers citing papers by Amy Powers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Powers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Powers. The network helps show where Amy Powers may publish in the future.

Co-authors

The 25 scholars most cited alongside Amy Powers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Amy Powers Line = papers co-authored together Amy Powers links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Germline BAP1 mutations predispose to malignant mesothelioma
Hit paper breakdown →
2011719
2 2002224
3 2012221
4 2015216
5 2012199
6 2000181
7 2015115
8 200291
9 199971
10 200867
11 199964
12 201059
13 201558
14 201458
15 200154
16 201440
17
Unique strains of SV40 in commercial poliovaccines from 1955 not readily identifiable with current testing for SV40 infection.
199934
18 201432
19 201624
20 201621

About Amy Powers

Amy Powers is a scholar working on Biochemistry, Pulmonary and Respiratory Medicine, Hematology, Clinical Biochemistry and Management of Technology and Innovation, having authored 40 papers that have together received 2.7k indexed citations. Recurring topics across this work include Occupational and environmental lung diseases (17 papers), Medical Imaging and Pathology Studies (8 papers), Blood groups and transfusion (6 papers), Blood transfusion and management (5 papers), Polyomavirus and related diseases (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers), Advanced Glycation End Products research (3 papers) and Blood donation and transfusion practices (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.4k citations), Biotechnology (215 citations), Oncology (671 citations), Biochemistry (110 citations) and Clinical Biochemistry (117 citations). Amy Powers has collaborated with scholars based in United States, Italy and Türkiye. Frequent co-authors include Michele Carbone, Harvey I. Pass, Haining Yang, Giovanni Gaudino, Mika Tanji, Paola Rizzo, Joseph R. Testa, Masaki Nasu, Sabahattin Cömertpay and A. Umran Doğan. Their work appears in journals such as Transfusion, Frontiers in Immunology, Transfusion Medicine Reviews, Journal of Translational Medicine and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026